Benzinga Rankings give you vital metrics on any stock – anytime.
Explore INmune Bio stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for INMB.
You can purchase shares of INmune Bio (NASDAQ:INMB) through any online brokerage.
Other companies in INmune Bio’s space includes: Molecular Partners (NASDAQ:MOLN), Innate Pharma (NASDAQ:IPHA), 4D Molecular Therapeutics (NASDAQ:FDMT), Monopar Therapeutics (NASDAQ:MNPR) and Larimar Therapeutics (NASDAQ:LRMR).
INmune Bio has a consensus price target of $18.29.
The stock price for INmune Bio (NASDAQ: INMB) is $7.74 last updated March 3, 2025 at 4:00 PM EST.
There are no upcoming dividends for INmune Bio.
INmune Bio’s Q1 earnings are confirmed for Thursday, May 8, 2025.
There is no upcoming split for INmune Bio.
INmune Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.